Qianjiang Yongan Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Qianjiang Yongan Pharmaceutical has a total shareholder equity of CN¥2.0B and total debt of CN¥20.0M, which brings its debt-to-equity ratio to 1%. Its total assets and total liabilities are CN¥2.3B and CN¥236.9M respectively. Qianjiang Yongan Pharmaceutical's EBIT is CN¥14.8M making its interest coverage ratio -0.4. It has cash and short-term investments of CN¥880.1M.
Key information
1.0%
Debt to equity ratio
CN¥20.00m
Debt
| Interest coverage ratio | -0.4x |
| Cash | CN¥880.13m |
| Equity | CN¥2.04b |
| Total liabilities | CN¥236.93m |
| Total assets | CN¥2.28b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 002365's short term assets (CN¥1.1B) exceed its short term liabilities (CN¥208.5M).
Long Term Liabilities: 002365's short term assets (CN¥1.1B) exceed its long term liabilities (CN¥28.4M).
Debt to Equity History and Analysis
Debt Level: 002365 has more cash than its total debt.
Reducing Debt: 002365's debt to equity ratio has increased from 0.5% to 1% over the past 5 years.
Debt Coverage: 002365's debt is well covered by operating cash flow (600.5%).
Interest Coverage: 002365 earns more interest than it pays, so coverage of interest payments is not a concern.